0
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.20.129.188. Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Thomas W. LeBlanc, MD, MA
JAMA Intern Med. 2016;176(2):265-266. doi:10.1001/jamainternmed.2015.6994.

Research Letter | 
Oreofe O. Odejide, MD; Angel M. Cronin, MS; Nolan Condron, BS; et al.
JAMA Intern Med. 2016;176(2):263-265. doi:10.1001/jamainternmed.2015.6599.

Clinical Observation | 
Laura Rosiñol, MD; Silvia Montoto, MD; Maria Teresa Cibeira, MD; et al.
Arch Intern Med. 2005;165(4):464-465. doi:10.1001/archinte.165.4.464.

Clinical Observation | 
Paul S. Mueller, MD; Christine L. Terrell, MD; Morie A. Gertz, MD
Arch Intern Med. 2002;162(11):1305-1309. doi:10.1001/archinte.162.11.1305.

Original Investigation |  FREE
Elizabeth W. Karlson, MD; Milenko Tanasijevic, MD; Susan E. Hankinson, ScD; et al.
Arch Intern Med. 2001;161(6):864-867. doi:10.1001/archinte.161.6.864.

Original Investigation |  FREE
Joan Bladé, MD; Patricia Fernández-Llama, MD; Francesc Bosch, MD; et al.
Arch Intern Med. 1998;158(17):1889-1893. doi:10.1001/archinte.158.17.1889.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Internal Medicine Collections
From The JAMA Network
JAMA Oncology
Viewpoint  | 
The “Next Big Thing” in Treatment for Relapsed or Refractory Multiple Myeloma May Be Held Back by Design—Between the Lines
Kai Ruggeri, PhD; Áine Maguire, MSc; Gordon Cook, MD
JAMA Ophthalmology
JAMA Ophthalmology Clinical Challenge  | 
Angiographically Silent Macular Edema
Shivani V. Reddy, MD; Shorye Payne, MD; Shlomit Schaal, MD, PhD
JAMA
Viewpoint  | 
The Ethical Challenges of Compassionate Use
Arthur L. Caplan, PhD; Amrit Ray, MD, MBA
JAMA Oncology
JAMA Oncology Clinical Challenge  | 
Bilateral Foot Gangrene
Konrad H. Stopsack, MD, MPH; Mithun Vinod Shah, MD, PhD